{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:00:51Z","timestamp":1789012851453,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3021,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bbmt.2006.09.005","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T07:59:01Z","timestamp":1168502341000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience"],"prefix":"10.1016","volume":"13","author":[{"given":"Martha L.","family":"Arellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Langston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Winton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.09.005_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/1042819021000050061","article-title":"Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia","volume":"44","author":"Gilleece","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2006.09.005_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib5","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood.V83.11.3377.3377","article-title":"Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse","volume":"83","author":"Van Rhee","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199401133300204","article-title":"Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia","volume":"330","author":"Porter","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.09.005_bib7","first-page":"998","article-title":"Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia","volume":"89","author":"Ferrara","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2006.09.005_bib8","first-page":"221","article-title":"Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation","volume":"5","author":"Zeder","year":"1998","journal-title":"Cancer Res Ther Control"},{"key":"10.1016\/j.bbmt.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bmt.1701496","article-title":"Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells","volume":"22","author":"Verdonck","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1704645","article-title":"Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant","volume":"34","author":"Eapen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbmt.2003.08.003","article-title":"Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia","volume":"9","author":"Meshinchi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","article-title":"Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens","volume":"11","author":"Radich","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib13","first-page":"641","article-title":"Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation","volume":"14","author":"Browett","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib14","first-page":"456","article-title":"Treatment of leukemia relapsed after allogeneic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases","volume":"44","author":"Sanz Rodriguez","year":"1999","journal-title":"Sangre (Barc)"},{"key":"10.1016\/j.bbmt.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403093","article-title":"Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)","volume":"17","author":"Wassmann","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/sj.leu.2402729","article-title":"Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic leukemia","volume":"16","author":"Visani","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.leu.2401641","article-title":"Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia","volume":"14","author":"Visani","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0925-5710(97)00081-9","article-title":"Interferon-alpha treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation","volume":"67","author":"Nagafuji","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib19","first-page":"119","article-title":"Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment","volume":"5","author":"Lowdell","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.bbmt.2006.09.005_bib20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bmt.1700793","article-title":"Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferon-alpha 2b","volume":"19","author":"Singhal","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1034\/j.1399-3046.2002.02033.x","article-title":"Treatment of leukemia relapse with recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) following unrelated umbilical cord blood transplant: induction of graft-vs.-leukemia","volume":"6","author":"Worth","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2141.1994.tb06746.x","article-title":"Unexpected remission of acute myeloid leukaemia after GM-CSF","volume":"87","author":"Bassan","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib23","first-page":"133","article-title":"Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation","volume":"16","author":"Mehta","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1445-5994.2001.00013.x","article-title":"Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation","volume":"31","author":"Grigg","year":"2001","journal-title":"Intern Med J"},{"key":"10.1016\/j.bbmt.2006.09.005_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0145-2126(94)00162-4","article-title":"Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612)","volume":"19","author":"Slovak","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2006.09.005_bib26","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib27","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib28","first-page":"20405","article-title":"Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation","author":"Levine","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib29","unstructured":"National Marrow Donor Program. Available at: www.nmdp.org. Accessed 2005."},{"key":"10.1016\/j.bbmt.2006.09.005_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1705207","article-title":"Allogeneic stem-cell transplantation in patients with refractory acute leukemia; a long-term follow-up","volume":"37","author":"Oyekunle","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbmt.2004.10.008","article-title":"Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation","volume":"11","author":"Wong","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","article-title":"Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia","volume":"9","author":"Doney","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/asheducation-2002.1.162","article-title":"Acute lymphoblastic leukemia","author":"Hoelzer","year":"2002","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2006.09.005_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V88.2.714.bloodjournal882714","article-title":"Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective","volume":"88","author":"Enright","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbmt.2003.08.004","article-title":"A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome","volume":"9","author":"Fung","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1700720","article-title":"Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy","volume":"19","author":"Mehta","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib37","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2001.19.16.3675","article-title":"Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation","volume":"19","author":"Bosi","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2141.1991.tb08083.x","article-title":"Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission","volume":"79","author":"Barrett","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2141.2001.03150.x","article-title":"Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +\/\u2212 Ida) and second allogeneic stem cell transplant","volume":"115","author":"Pawson","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1703859","article-title":"Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved","volume":"31","author":"Massenkeil","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bmt.1705123","article-title":"Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias","volume":"36","author":"Massenkeil","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib44","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","article-title":"Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation","volume":"87","author":"Slavin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.09.005_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.leu.2401033","article-title":"GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia","volume":"12","author":"Cortes","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1521-6926(04)00051-9","article-title":"In-vivo generation of leukaemia-derived dendritic cells","volume":"17","author":"Kolb","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2006.09.005_bib47","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.leu.2402710","article-title":"Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts","volume":"16","author":"Mohty","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.leu.2401685","article-title":"Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells","volume":"14","author":"Boyer","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2006.09.005_bib49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbmt.2004.05.007","article-title":"Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation","volume":"10","author":"Li","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.09.005_bib50","first-page":"19","article-title":"DC2 effect on survival following allogeneic bone marrow transplantation","volume":"16","author":"Waller","year":"2002","journal-title":"Oncology"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106006422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:27:10Z","timestamp":1761056830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106006422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1083879106006422"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}